(Q61066427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Screening of protease inhibitors as antiplasmodial agents. Part I: Aziridines and epoxides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Franziska Schulz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Christoph Gelhaus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Björn Degel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Radim Vicik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Saskia Heppner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Alexander Breuning

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Matthias Leippe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jiri Gut

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Philip J Rosenthal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1214-1224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

Drug resistance in malaria

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Chemotherapeutic agents against malaria: what next after chloroquine?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Cysteine proteases of malaria parasites

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Probing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: comparative protein modeling and docking studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Blocking effect of a biotinylated protease inhibitor on the egress of Plasmodium falciparum merozoites from infected red blood cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Hemoglobin metabolism in the malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

The proteases and pathogenicity of parasitic protozoa

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Cysteine proteases of malaria parasites: targets for chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Aziridide-Based Inhibitors of Cathepsin L: Synthesis, Inhibition Activity, and Docking Studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Antimalarial synergy of cysteine and aspartic protease inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Simple, fast, and accurate fluorometric method to determine drug susceptibility of Plasmodium falciparum in 24-well suspension cultures.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Electron-Density Determination of Electrophilic Building Blocks as Model Compounds for Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Synthesis of chiral pilocarpine analogues via a C-8 ketone intermediate

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

aziridinyl peptides as inhibitors of cysteine proteases: Effect of a free carboxylic acid function on inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Human malaria parasites in continuous culture

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700070

7 January 2021

Identifiers

DOI

10.1002/CMDC.200700070

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17562535%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference